|
Printable version |
From: | "tennyson@caverock.net.nz" <tennyson@caverock.net.nz> |
Date: | Tue, 06 May 2003 13:24:33 +1200 |
Hi Gerry, > > > You referred to GENESIS. > > I happened to know the competing drugs (first posts of the following > web site): > > http://www.sharetrader.co.nz/topic.asp?TOPIC_ID=17488&whichpage=4&Sear > chTerms=GENESIS > > Then the relevation that GEN had 135 scientists-it really shook me. > > Most Sharetrader people didn't wait with ditching their shares. > > I read to the end of that thread. You guys have really put on the white lab coats with your biotech research. Well done! I wouldn't be so concerned about the number of scientists myself. I'm more interested in their productivity! I notice you haven't commented so much on the 'plant' side of the business though. I have always thought that this was the best bet for Genesis research, rather than trying to out muscle the Americans at their own game on the 'health' side of the business. I think it is this side of the business that WRI sees the potential in. On another note I think I may have made a mistake estimating the number of Genesis Research shares on issue. Is there a GEN shareholder out there who can confirm the number of shares on issue now? SNOOPY -- Message sent by Snoopy on Pegasus Mail version 4.02 ---------------------------------- "Q: If you call a dog tail a leg, how many legs does a dog have?" "A: Four. Calling a tail a leg doesn't make it a leg." ---------------------------------------------------------------------------- To remove yourself from this list, please use the form at http://www.sharechat.co.nz/chat/forum/
References
|